These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21448110)

  • 1. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
    Pérez-Iglesias R; Ortiz-Garcia de la Foz V; Martínez García O; Amado JA; Garcia-Unzueta MT; Ayesa-Arriola R; Suarez-Pinilla P; Tabares-Seisdedos R; Crespo-Facorro B
    Schizophr Res; 2014 Oct; 159(1):90-4. PubMed ID: 25151200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
    Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
    Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful quetiapine therapy in psychotic patients with mood elevation].
    Kecskés I
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):259-63. PubMed ID: 20150663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia in a patient treated with quetiapine.
    Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
    World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nizatidine for the treatment of patients with quetiapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B; Kilic N
    Hum Psychopharmacol; 2004 Jan; 19(1):37-40. PubMed ID: 14716710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of atypical antipsychotics and weight gain.
    Sussman N
    J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology of weight gain with antipsychotics.
    Casey DE; Zorn SH
    J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of QTc prolongation due to combination of ziprasidone and quetiapine].
    Minov C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S142-4. PubMed ID: 15570533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents.
    Swadi HS; Craig BJ; Pirwani NZ; Black VC; Buchan JC; Bobier CM
    Int Clin Psychopharmacol; 2010 Jan; 25(1):1-6. PubMed ID: 19809337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic treatment of psychosis associated with multiple sclerosis.
    Davids E; Hartwig U; Gastpar M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):743-4. PubMed ID: 15276702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic treatment--side-effect and/or metabolic syndrome.
    Dadić-Hero E; Ružić K; Grahovac T; Palijan TZ; Petranović D; Sepić-Grahovac D
    Psychiatr Danub; 2011 Mar; 23(1):98-100. PubMed ID: 21448108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study.
    Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P
    J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
    Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
    Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of atypical antipsychotics in pediatric bipolar disorder.
    Chang KD
    J Clin Psychiatry; 2008; 69 Suppl 4():4-8. PubMed ID: 18533762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
    Chen CK; Chen YC; Huang YS
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of metabolic risk factors in an inpatient psychiatric setting.
    Coakley C; Bolton P; Flaherty L; Kopeski LM; Slifka K; Sutherland MA
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):24-30. PubMed ID: 22329619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of quetiapine side effects.
    Garver DL
    J Clin Psychiatry; 2000; 61 Suppl 8():31-3; discussion 34-5. PubMed ID: 10811241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.